G. Wong

发表

Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragments

M. Ngu, G. Wong, V W-S Wong, 2014, Alimentary pharmacology & therapeutics.

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

V. Wong, J. Sung, W. So, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Artificial intelligence in prediction of non‐alcoholic fatty liver disease and fibrosis

V. Wong, P. Yuen, A. Chan, 2021, Journal of gastroenterology and hepatology.

Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: comparison of shear-wave elastography and transient elastography with liver biopsy correlation.

Anil T Ahuja, Jiayun Shen, V. Wong, 2013, Radiology.

How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?

E. Gane, G. Wong, A. Lok, 2022, Journal of hepatology.

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

K. Chow, P. Chan, G. Joynt, 2021, Gut.

Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study

Jun Yu, V. Wong, J. Sung, 2013, PloS one.

Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment

V. Wong, Y. Chawla, Y. Ni, 2018, Journal of gastroenterology and hepatology.

Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial

V. Wong, F. Chan, J. Sung, 2007, The Lancet.

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis

V. Wong, G. Wong, H. Chan, 2013, Hepatology.

Explainable Uncertainty-Aware Convolutional Recurrent Neural Network for Irregular Medical Time Series

Baoyao Yang, Mang Ye, Qingxiong Tan, 2020, IEEE Transactions on Neural Networks and Learning Systems.

Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial

S. Ng, F. Chan, Justin C.Y. Wu, 2017, The Lancet.

Treatments of Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection: Treat HBV-related HCC

G. Wong, C. Chong, G. Wong, 2016 .

Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease

V. Wong, G. Wong, Guanlin Li, 2021, Journal of clinical and translational hepatology.

Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog

V. Wong, H. Chan, G. Lui, 2021, Clinical and translational gastroenterology.

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.

V. Wong, V. de Lédinghen, P. Bossuyt, 2023, The lancet. Gastroenterology & hepatology.

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

Vincent Wai-Sun Wong, Grace Lai-Hung Wong, V. Wong, 2015, Gut.

Higher Estimated Net Endogenous Acid Production May Be Associated with Increased Prevalence of Nonalcoholic Fatty Liver Disease in Chinese Adults in Hong Kong

V. Wong, F. Chan, D. Yeung, 2015, PloS one.

Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia

G. Wong, G. Lui, S. H. Lee, 2023, HIV medicine.

Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients

V. Wong, H. Chan, A. Chan, 2017, Hepatology.

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis

V. Wong, S. Chan, Y. Lim, 2019, Alimentary pharmacology & therapeutics.

Pattern and impact of hepatic adverse events encountered during immune checkpoint inhibitors – A territory‐wide cohort study

V. Wong, T. Mok, G. Wong, 2020, Cancer medicine.

Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B

V. Wong, H. Chan, G. Lui, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients

V. Wong, T. Mok, H. Chan, 2015, Proceedings of the National Academy of Sciences.

V. Wong, V. de Lédinghen, S. Sookoian, 2022, Hepatology.

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

Julien Vergniol, V. Wong, V. de Lédinghen, 2010, Hepatology.

Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients.

V. Wong, G. Wong, H. Chan, 2011, The Journal of infectious diseases.

A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B

V. Wong, G. Wong, H. Chan, 2010, Hepatology.

Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B

J. Sung, G. Wong, A. Chim, 2007, Alimentary pharmacology & therapeutics.

Significantly Lower Case-fatality Ratio of Coronavirus Disease 2019 (COVID-19) than Severe Acute Respiratory Syndrome (SARS) in Hong Kong—A Territory-Wide Cohort Study

V. Wong, H. Chan, D. Hui, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19

V. Wong, H. Chan, D. Hui, 2020, Gut.

Noninvasive biomarkers in NAFLD and NASH — current progress and future promise

V. de Lédinghen, S. Sookoian, G. Wong, 2018, Nature Reviews Gastroenterology & Hepatology.

Risks of AKI and Major Adverse Clinical Outcomes in Patients with Severe Acute Respiratory Syndrome or Coronavirus Disease 2019.

V. Wong, H. Chan, C. Szeto, 2021, Journal of the American Society of Nephrology : JASN.

The Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 2: Management and special groups

V. Wong, Y. Chawla, Y. Ni, 2018, Journal of gastroenterology and hepatology.

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.

Jisoo A. Kwon, R. Malekzadeh, F. Tacke, 2023, The lancet. Gastroenterology & hepatology.

Review article: long‐term safety of oral anti‐viral treatment for chronic hepatitis B

M. Yuen, G. Wong, H. Chan, 2018, Alimentary pharmacology & therapeutics.

Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir

V. Wong, G. Wong, T. Yip, 2022, JAMA network open.

Epidemiology, Symptomatology, and Risk Factors for Long COVID Symptoms: Population-Based, Multicenter Study

F. K. Chan, Y. Wing, G. Wong, 2022, JMIR public health and surveillance.

Risk of HCC in Patients with HBV, Role of Antiviral Treatment

V. Wong, G. Wong, L. Liang, 2022, Current Hepatology Reports.

Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?

G. Wong, T. Yip, J. Lai, 2020, Journal of Gastroenterology.

Residual risk of HCC during long-term oral nucleos(t)ide analogues (NUCs) in patients with CHB - Is one NUC better than the other?

P. Lampertico, G. Wong, G. Wong, 2019, Journal of hepatology.

Bacterial Microbiota Profiling in Gastritis without Helicobacter pylori Infection or Non-Steroidal Anti-Inflammatory Drug Use

Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Chunming Ding, 2009, PloS one.

Prediction of fibrosis progression in chronic viral hepatitis

G. Wong, G. Wong, 2014, Clinical and molecular hepatology.

Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement

V. Wong, H. Chan, Yasuhito Tanaka, 2020, The Lancet Gastroenterology & Hepatology.

Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis

A. Cheng, Qianben Wang, P. Lai, 2018, Nucleic acids research.

Association of genetic variations with NAFLD in lean individuals

A. Chan, G. Wong, A. Chim, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy

V. Wong, D. Yeung, J. Woo, 2015, The American Journal of Gastroenterology.

PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome

V. Wong, D. Yeung, J. Woo, 2014, Alimentary pharmacology & therapeutics.

Non-invasive tests of non-alcoholic fatty liver disease

V. Wong, G. Wong, L. Liang, 2022, Chinese medical journal.

Implications of Abdominal Adipose Tissue Distribution on Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: A Chinese General Population Study

V. Wong, W. Chu, D. Yeung, 2021, Clinical and translational gastroenterology.

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

S. Sarin, A. Dokmeci, S. Hamid, 2021, Hepatology International.

Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values

V. Wong, V. de Lédinghen, F. Marra, 2017, Hepatology.

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease

V. Wong, F. Chan, J. Sung, 2011, Gut.

Respiratory admissions before and during the COVID‐19 pandemic with mediation analysis of air pollutants, mask‐wearing and influenza rates

G. Wong, K. Chan, D. Hui, 2022, Respirology.

Machine learning model to predict recurrent ulcer bleeding in patients with history of idiopathic gastroduodenal ulcer bleeding

V. Wong, F. Chan, J. Lau, 2019, Alimentary pharmacology & therapeutics.

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Jun Yu, 2010, Gut.

Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases.

Vincent Wai-Sun Wong, Grace Lai-Hung Wong, V. Wong, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Validation of the NAFLD Fibrosis Score in a Chinese Population With Low Prevalence of Advanced Fibrosis

V. Wong, F. Chan, J. Sung, 2008, The American Journal of Gastroenterology.

Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B.

Rui Huang, Chao Wu, Hwai I. Yang, 2019, The American journal of gastroenterology.

New simple prognostic score for primary biliary cirrhosis: Albumin‐bilirubin score

V. Wong, A. Chan, K. To, 2015, Journal of gastroenterology and hepatology.

A Retrospective Study on Clinical Features and Prognostic Factors of Biopsy-Proven Primary Biliary Cirrhosis in Chinese Patients

V. Wong, F. Chan, J. Sung, 2005, The American Journal of Gastroenterology.

Interaction of Adipokines and Hepatitis B Virus on Histological Liver Injury in the Chinese

Jun Yu, A. Cheng, V. Wong, 2010, The American Journal of Gastroenterology.

Surrogate end points and long-term outcome in patients with chronic hepatitis B.

V. Wong, J. Sung, S. Tsang, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B

V. Wong, F. Chan, J. Sung, 2008, Gut.

High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.

V. Wong, T. Mok, W. Yeo, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cost effectiveness of response-guided therapy with peginterferon in the treatment of chronic hepatitis B.

V. Wong, H. Chan, G. Wong, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Development of a Novel Inflammation-Based Index for Hepatocellular Carcinoma

V. Wong, H. Reeves, A. Chan, 2019, Liver Cancer.

UA-CRNN: Uncertainty-Aware Convolutional Recurrent Neural Network for Mortality Risk Prediction

Pong C. Yuen, Baoyao Yang, Mang Ye, 2019, CIKM.

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

V. Wong, J. Sung, T. Mok, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease

V. Wong, Han‐Chieh Lin, Yi‐Hsiang Huang, 2023, Hepatobiliary & Pancreatic Diseases International.

Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes.

V. Wong, A. Kong, E. Lau, 2017, Journal of hepatology.

N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD

V. Wong, G. Targher, G. Wong, 2022, Hepatology International.

Pathogenesis and novel treatment options for non-alcoholic steatohepatitis.

Jun Yu, V. Wong, H. Chan, 2016, The lancet. Gastroenterology & hepatology.

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.

M. Kumar, V. Wong, V. de Lédinghen, 2017, Journal of hepatology.

Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®.

V. Wong, V. de Lédinghen, H. Chan, 2012, Journal of hepatology.

Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD.

V. Wong, M. Zheng, C. Byrne, 2021, Metabolism: clinical and experimental.

A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients

V. Wong, M. Karsdal, K. Duffin, 2020, The American journal of gastroenterology.

Impact of Obesity and ALT Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in NAFLD Patients

V. Wong, A. Chan, E. Bugianesi, 2020 .

Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial.

V. Wong, F. Chan, J. Sung, 2013, Journal of hepatology.

Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory‐Wide Cohort Study

V. Wong, H. Chan, G. Wong, 2021, Hepatology communications.

Application of transient elastography in nonalcoholic fatty liver disease

V. Wong, G. Wong, Xinrong Zhang, 2019, Clinical and molecular hepatology.

Update of liver fibrosis and steatosis with transient elastography (Fibroscan)

G. Wong, G. Wong, 2013, Gastroenterology report.

An Aging Population of Chronic Hepatitis B With Increasing Comorbidities: A Territory‐Wide Study From 2000 to 2017

V. Wong, H. Chan, G. Lui, 2019, Hepatology.

Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B.

V. Wong, H. Chan, G. Lui, 2018, Journal of hepatology.

Metabolic syndrome increases cardiovascular events but not hepatic events and death in patients with chronic hepatitis B

V. Wong, G. Wong, A. Chim, 2016, Hepatology.

Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment

S. Hamilton-Dutoit, H. Møller, H. Chan, 2018, Journal of gastroenterology and hepatology.

Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID‐19

V. Wong, H. Chan, D. Hui, 2021, Hepatology.

Glucose-lowering drugs and outcome from COVID-19 among patients with type 2 diabetes mellitus: a population-wide analysis in Hong Kong

V. Wong, A. Luk, R. Ma, 2021, BMJ Open.

ACE inhibitors prevent liver-related events in non-alcoholic fatty liver disease.

V. Wong, G. Wong, H. Chan, 2021, Hepatology.

Esomeprazole: a new proton pump inhibitor for NSAID-associated peptic ulcers and dyspepsia

J. Sung, G. Wong, G. Wong, 2006 .

Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease

V. Wong, G. Wong, J. Foucher, 2019, Liver international : official journal of the International Association for the Study of the Liver.

DATA-GRU: Dual-Attention Time-Aware Gated Recurrent Unit for Irregular Multivariate Time Series

Baoyao Yang, Mang Ye, Qingxiong Tan, 2020, AAAI.

Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma.

Jun Yu, A. Cheng, V. Wong, 2015, Cancer research.

Histone Deacetylase HDAC 8 Promotes Insulin Resistance and b-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

Jun Yu, A. Cheng, V. Wong, 2015 .

Lymphoepithelioma-like Hepatocellular Carcinoma: An Uncommon Variant of Hepatocellular Carcinoma With Favorable Outcome

V. Wong, P. Lai, A. Chan, 2015, The American journal of surgical pathology.

Tenofovir alafenamide is associated with improved alanine aminotransferase and renal safety compared to tenofovir disoproxil fumarate

V. Wong, G. Wong, H. Chan, 2022, Journal of medical virology.

Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study

Chao Wu, M. Yuen, Chien-Hung Chen, 2021, Hepatology International.

HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues.

V. Wong, G. Wong, H. Chan, 2019, Journal of hepatology.

Virus and Host Testing to Manage Chronic Hepatitis B.

V. Wong, H. Chan, G. Wong, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

On‐treatment alpha‐fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir

Yee-Kit Tse, V. Wong, G. Wong, 2014, Hepatology.

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

V. Wong, J. Sung, G. Wong, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Liver Stiffness Measurement by Transient Elastography as a Predictor on Posthepatectomy Outcomes

V. Wong, P. B. Lai, A. Chan, 2013, Annals of Surgery.

Fatty Pancreas, Insulin Resistance, and β-Cell Function: A Population Study Using Fat-Water Magnetic Resonance Imaging

V. Wong, A. Kong, D. Yeung, 2014, The American Journal of Gastroenterology.

2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report

V. Wong, M. Jadoul, J. Fung, 2020, Kidney international reports.

One‐stop clinic for ketamine‐associated uropathy: report on service delivery model, patients' characteristics and non‐invasive investigations at baseline by a cross‐sectional study in a prospective cohort of 318 teenagers and young adults

V. Wong, H. Chan, P. Lai, 2014, BJU international.

Liver injury is common among chronic abusers of ketamine.

V. Wong, H. Chan, P. Lai, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Non‐invasive assessments for liver fibrosis: The crystal ball we long for

G. Wong, G. Wong, 2018, Journal of gastroenterology and hepatology.

Advances in the diagnosis and treatment of liver fibrosis

G. Wong, J. Cheng, G. Wong, 2017 .

Noninvasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B

V. Wong, G. Wong, A. Chim, 2015, Journal of gastroenterology and hepatology.

Non‐invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B

G. Wong, P. Choi, H. Chan, 2014, Alimentary pharmacology & therapeutics.

Transient elastography: Kill two birds with one stone?

G. Wong, G. Wong, 2013, World journal of hepatology.

Transient Elastography (Fibroscan®): A New Look of Liver Fibrosis and Beyond

S. Rahman, H. Ozkan, G. Wong, 2013 .

The effect of caffeine and alcohol consumption on liver fibrosis – a study of 1045 Asian hepatitis B patients using transient elastography

V. Wong, H. Chan, G. Wong, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Development of a non‐invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B

G. Wong, P. Choi, H. Chan, 2010, Alimentary pharmacology & therapeutics.

Alanine aminotransferase‐based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B

A. Chan, G. Wong, P. Choi, 2009, Journal of viral hepatitis.

Non-invasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B 1 Running title : LSM and Hui index predict survival in CHB

V. Wong, H. Chan, G. Wong, 2014 .

Natural history of chronic hepatitis B

V. Wong, H. Chan, G. Wong, 2009 .

High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis

V. Wong, F. Chan, J. Sung, 2011, Gut.

Changes in Crohn's disease phenotype over time in the Chinese population: Validation of the Montreal classification system

F. Chan, J. Sung, W. Leung, 2008, Inflammatory bowel diseases.

Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter.

V. Wong, V. de Lédinghen, A. Tuttolomondo, 2017, Journal of hepatology.

High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers.

V. Wong, F. Chan, J. Sung, 2009, Gastroenterology.

Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse

V. Wong, H. Chan, P. Lai, 2016, Histopathology.

Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection

Catherine S. K. Cheung, V. Wong, G. Wong, 2023, Alimentary pharmacology & therapeutics.

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future

V. Wong, G. Wong, T. Yip, 2022, Clinical and molecular hepatology.

Long-Term follow-up of Lamivudine Treatment in Patients with Severe Acute Exacerbation of Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B

V. Wong, F. Chan, S. Tsang, 2008, Antiviral therapy.

Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease

V. Wong, V. de Lédinghen, H. Chan, 2019, Gut.

Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease

V. Wong, H. Chan, A. Chan, 2012, The American Journal of Gastroenterology.

Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis

V. Wong, Hwai I. Yang, Y. Wong, 2023, Clinical and molecular hepatology.

Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.

V. Wong, J. Woo, H. Chan, 2018, Journal of hepatology.

Trends in risk factor control and treatment among patients with non‐alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory‐wide study

V. Wong, S. Chan, G. Wong, 2023, Alimentary pharmacology & therapeutics.

Two are better than one: noninvasive assessment of liver fibrosis in nonalcoholic fatty liver disease

H. Chan, G. Wong, G. Wong, 2015, Hepatology International.

Baveno VII criteria identify varices needing treatment in patients with hepatocellular carcinoma of different Barcelona Clinic Liver Cancer stages

V. Wong, G. Wong, H. Chan, 2023, Journal of gastroenterology and hepatology.

Liver stiffness measurement predicts high‐grade post‐hepatectomy liver failure: A prospective cohort study

V. Wong, H. Chan, P. Lai, 2017, Journal of gastroenterology and hepatology.

Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.

V. Wong, H. Chan, G. Wong, 2014, Journal of hepatology.

Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy.

V. Wong, G. Wong, G. Wong, 2013, World journal of gastroenterology.

Tertiary Prevention of HBV-related HCC in Asia

V. Wong, G. Wong, C. Chong, 2013, Current Hepatitis Reports.

Prediction of HCC Using Liver Stiffness Measurements

G. Wong, G. Wong, 2020 .

Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population

H. Chan, G. Wong, A. Chim, 2011, Journal of gastroenterology and hepatology.

HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis

V. Wong, G. Wong, M. Nguyen, 2017, The American Journal of Gastroenterology.

Metabolic and histological features of non‐alcoholic fatty liver disease patients with different serum alanine aminotransferase levels

S. Tsang, F. Chan, J. Sung, 2009, Alimentary pharmacology & therapeutics.

Detecting Early‐Stage Liver Fibrosis Using Macromolecular Proton Fraction Mapping Based on Spin‐Lock MRI: Preliminary Observations

Weitian Chen, A. Chan, S. Yu, 2022, Journal of magnetic resonance imaging : JMRI.

Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.

V. Wong, H. El‐Serag, Jaw-Town Lin, 2018, Journal of hepatology.

High serum interleukin‐6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B

Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Jun Yu, 2009, International journal of cancer.

Letter: systematic review with meta‐analysis on the impact of functional cure on clinical outcomes in patients with chronic hepatitis B

V. Wong, H. Chan, T. Yip, 2022, Alimentary pharmacology & therapeutics.

Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.

V. Wong, H. Chan, G. Wong, 2017, Journal of hepatology.